Is Rocephine (ceftriaxone) 500mg Intramuscular (IM) single dose plus Doxycycline 100mg twice a day (BID) for 7 days an effective treatment regimen for gonorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone 500mg IM + Doxycycline 100mg BID for Gonorrhea

No, this regimen is NOT recommended—you must use azithromycin 1g orally as a single dose instead of doxycycline for gonorrhea treatment. 1, 2

Why Azithromycin is Required, Not Doxycycline

  • The CDC and American College of Physicians explicitly recommend ceftriaxone 500mg IM PLUS azithromycin 1g orally as a single dose as the standard treatment regimen for gonorrhea. 1

  • Azithromycin is given as a single 1g oral dose (not doxycycline) to address potential chlamydial coinfection and to potentially delay emergence of cephalosporin resistance. 1

  • While doxycycline 100mg BID for 7 days is effective for chlamydia treatment, it is not the preferred partner agent for gonorrhea because azithromycin provides single-dose convenience and may help prevent resistance development. 1

Evidence Comparing the Two Regimens

  • A 2013 retrospective study found no significant difference in retreatment rates between ceftriaxone plus azithromycin versus ceftriaxone plus doxycycline (adjusted hazard ratio 0.88,95% CI 0.69-1.12), suggesting doxycycline may be a reasonable alternative. 3

  • However, in the subanalysis of patients retested within 30 days, all retreated patients had received the doxycycline regimen, raising concerns about its efficacy. 3

  • Historical data from 1990 supports ceftriaxone 250mg IM plus doxycycline 100mg BID for 7 days for presumptive chlamydial coinfection treatment, but this predates current resistance patterns and guideline updates. 4

The Correct Regimen

Use ceftriaxone 500mg IM as a single dose PLUS azithromycin 1g orally as a single dose. 1

  • This combination has superior efficacy compared to all oral alternatives and is the only acceptable first-line regimen, particularly for pharyngeal gonorrhea which is significantly more difficult to eradicate. 1

  • The 500mg dose represents an increase from older 250mg guidelines due to antimicrobial stewardship concerns and evolving resistance patterns. 1

Critical Concurrent Management

  • Screen for syphilis with serology at the time of gonorrhea diagnosis. 1

  • Treat all sexual partners from the preceding 60 days; if last contact was >60 days before diagnosis, treat the most recent partner. 1

  • Instruct patients to avoid sexual intercourse until therapy is completed and both patient and partners are asymptomatic. 1

Follow-Up Requirements

  • Patients treated with the recommended ceftriaxone 500mg IM + azithromycin 1g regimen do not need routine test-of-cure unless symptoms persist. 1

  • Consider retesting at 3 months due to high reinfection risk. 1

Common Pitfall to Avoid

Do not substitute doxycycline for azithromycin in gonorrhea treatment—the single-dose azithromycin regimen is preferred for compliance, resistance prevention, and guideline adherence. 1, 3

References

Guideline

Treatment of Oral Gonorrhea with IM Ceftriaxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Azithromycin Treatment for Gonorrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Therapy for gonococcal infections: options in 1989.

Reviews of infectious diseases, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.